Skip to main content

Initial Trial Results of Mixing AstraZeneca, Sputnik V COVID Vaccines Show No Serious Adverse Avents

Moscow: The Russian Direct Investment Fund (RDIF)  on Friday announced the initial safety results of the world’s first study of a combination of the Oxford-AstraZeneca and Sputnik V COVID-19 vaccines. RDIF said that interim analysis of the data demonstrates a high safety profile for the combined use of the two vaccines with no serious adverse events or cases of coronavirus after vaccination.

“The heterogeneous boosting approach (“vaccine cocktail”) using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component) was at the core of Sputnik V, the world’s first registered vaccine against coronavirus,” read a statement issued by the RDIF.

Russia’s sovereign wealth fund announced initial safety results of the world’s first study of a combination between the COVID-19 vaccine developed jointly with the University of Oxford and the first component of the Russian COVID-19 vaccine (Sputnik Light vaccine based on human adenovirus serotype 26) in the Republic of Azerbaijan.

The RDIF initiated the study in December 2020. The first partnership of this kind was concluded in December 2020 in the presence of Russian President Vladimir Putin.

RDIF, The Gamaleya Center, AstraZeneca and R-Pharm signed a Memorandum of Intent aimed at cooperation in vaccine development.

The RDIF was the first in the World to initiate such a study in December 2020.

“The first partnership of this kind was concluded in December 2020 in the presence of the President of Russia Vladimir Putin. RDIF, The Gamaleya Center, AstraZeneca and R-Pharm signed a Memorandum of Intent aimed at cooperation in vaccine development,” said the RDIF statement.

Studies on the safety and immunogenicity of the combination of the AstraZeneca vaccine and the first component of the Sputnik V vaccine in Azerbaijan began in February 2021.

“To date, 50 volunteers have been vaccinated and new participants are invited to join the trial. Interim analysis of the data demonstrates a high safety profile for the combined use of the vaccines with no serious adverse events or cases of coronavirus after vaccination.”

According to the statement, the initial data on the immunogenicity of the combined use of AstraZeneca will be in August 2021.

“In August 2021, RDIF and partners will publish initial data on the immunogenicity of the combined use of the AstraZeneca vaccine and the first component of the Sputnik V vaccine in Azerbaijan. Clinical trials of a combination of vaccines are being carried out in several countries as part of a global program. Volunteers are being vaccinated in UAE, and regulatory approval to conduct trials has been granted in Russia and Belarus,” it said.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) said, “As new strains of Coronavirus emerge, partnerships between vaccine manufacturers and combining different vaccines are key to successfully fighting the pandemic. Based on the high efficacy of the heterogeneous boosting (“vaccine cocktail”) approach, RDIF was the first in the world to initiate partnerships with other coronavirus vaccine manufacturers.”

“The first partnership of this kind was a joint clinical trial with AstraZeneca. We look forward to its success in Azerbaijan and other countries, which will allow more effective implementation of vaccination programs and protect people around the world. We consider it important to conduct joint research on combining the first component of Sputnik V with vaccines from other manufacturers for a more effective fight against emerging new strains of coronavirus,” added Dmitriev.

Irina Panarina, General Manager, AstraZeneca Russia and Eurasia said, “A heterogeneous prime-boosting involving administering components of different vaccines to a patient is one of the most promising vaccination regimens to study.”

“It is becoming especially relevant now when the issue of preventing the spread of new strains of coronavirus infection is acute, and the need for revaccination of the population is also coming to a head. That is why the results of the study can be of great importance for those countries where both the vaccine by AstraZeneca and the University of Oxford and the Sputnik V vaccine are registered,” stated Panarina.

Vasily Ignatiev, CEO of R-Pharm Group, said, “The initial results obtained at times when the delta strain is spreading are very important for assessing the safety and early efficacy of the vaccine combination. We will continue researching and analyzing the data with the prospect of a publication in an international journal.”

(With ANI inputs)



source https://www.india.com/news/india/astrazeneca-sputnik-v-covid-vaccine-cocktail-combination-initial-trial-results-4852919/

Comments

Popular posts from this blog

Delhi-NCR Rains LIVE Updates: Thunderstorm With Moderate to Heavy Rains Likely in Delhi, Gurugram, Faridabad and Adjoining Areas

Delhi-NCR Rains: The national capital and its neighbouring areas are likely to witness thunderstorms with moderate to heavy intensity rains during the next two hours on Wednesday, as per the predictions notified by the Indian Meteorological Department (IMD). The downpour will occur over and adjoining areas of Delhi-NCR. Taking to Twitter, the Met department said, “Thunderstorm with moderate to heavy intensity rain would occur over and adjoining areas of isolated places of Delhi (Lodi road, IGI airport ), NCR (Gurugram, Manesar, Faridabad, Ballabhgarh) Tosham, Bhiwani, Charkhi Dadri, Mattanhail, Jhajjar, Narnaul, Mahendargarh, Kosali, Farukhnagar, Bawal, Nuh, Sohana, Hodal, Palwal (Haryana) Barsana, Nandgaon (UP) Viratnagar, Kotputli, Khairthal, Bhiwari, Laxmangarh, Nadbai, Nagar, Alwar, Tizara, Deeg (Rajasthan) during next 2 hours,” tweeted IMD. Earlier on Tuesday, heavy rains lashed several parts of Delhi causing waterlogging and affecting the vehicular movement in parts of the city ...

MP: Woman Forced To Undergo ‘Purification’ For Marrying Dalit Man

Betul: A 24-year-old woman from Madhya Pradesh’s Betul district was allegedly forced to undergo a “purification” ritual by her father and other relatives wherein she was forced to take bath in the Narmada river, her hair trimmed and her clothes discarded for marrying a Dalit man, police said on Saturday. Police have registered a case against the woman’s father and three of his relatives on Saturday after the woman lodged a complaint, said Betul Kotwali police station in-charge Ratnakar Hingve. On Friday, the woman submitted a complaint to Superintendent of Police (SP) Simala Prasad. The complainant alleged that she had married a Dalit man in March 2020. She said her family members filed a missing person complaint in January 2021, though her father knew about her whereabouts and used to meet her. “I got married on March 11, 2020, and informed my father on January 4, 2021. My father continued to meet me but despite that, he filed a missing person complaint on January 10, 2021, at Chop...

India, Russia Sign Record 28 MoUs, Programme of Cooperation In Defence For 10 Years | Key Points

New Delhi: India and Russia have been in regular touch on Afghanistan and regional issues, Prime Minister Narendra Modi said on Monday and noted that the two countries have not only helped each other without hesitation but also taken care of each others’ sensitivities. The Prime Minister, who held the annual summit meeting with Russian President Vladimir Putin at Hyderabad House here, said the 2+2 mechanism between the two countries has started a new mechanism to increase cooperation between the two countries. “Both countries have not only helped each other without any hesitation but have also taken care of each others’ sensitivities. This is really a unique and trustworthy model of intrusted friendship,” he said. This is the first in-person between PM Modi and Putin since they met on the sidelines of the BRICS summit in 2019 in Brasilia. The visit of the Russian leader is in continuation of the tradition of annual summits held alternately in India and Russia. Key Takeaways from ...